These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 11570263
21. The epidemiology of drug abuse: current issues. Current program dimensions. Myrick R. NIDA Res Monogr; 1977 Mar; (10):238-43. PubMed ID: 405605 [No Abstract] [Full Text] [Related]
22. Planning the new national institute on substance use and addiction disorders. Nestler EJ, Krystal JH. Biol Psychiatry; 2012 Aug 01; 72(3):166-7. PubMed ID: 22683089 [No Abstract] [Full Text] [Related]
23. NIDA's role in war on drugs. Science; 1988 Oct 07; 242(4875):15-6. PubMed ID: 2845574 [No Abstract] [Full Text] [Related]
24. Human neuroscience at National Institute on Drug Abuse: implications for genetics research. Gordon HW. Am J Med Genet; 1994 Dec 15; 54(4):300-3. PubMed ID: 7726199 [Abstract] [Full Text] [Related]
25. HIV report. J Nurs Adm; 1991 Nov 15; 21(11):11. PubMed ID: 1941162 [No Abstract] [Full Text] [Related]
26. HIV outreach and substance abuse treatment for Latino drug users: Implications for program planning. Lundgren LM, Delgado M. Eval Program Plann; 2008 Feb 15; 31(1):61-3. PubMed ID: 18222141 [No Abstract] [Full Text] [Related]
27. Human immunodeficiency virus type 1 infection, mucosal immunity, and pathogenesis and extramural research programs at the National Institutes of Health. Kresina TF, Mathieson B. J Infect Dis; 1999 May 15; 179 Suppl 3():S392-6. PubMed ID: 10099104 [No Abstract] [Full Text] [Related]
28. HIV/AIDS. Where have all the dollars gone? Cohen J. Science; 2008 Jul 25; 321(5888):520. PubMed ID: 18653878 [No Abstract] [Full Text] [Related]
29. A research agenda for economic evaluation of substance abuse services. French MT, Drummond M. J Subst Abuse Treat; 2005 Sep 25; 29(2):125-37. PubMed ID: 16135341 [Abstract] [Full Text] [Related]
31. HIV clinical guidelines. N J Med; 1994 Apr 25; 91(4):203-4. PubMed ID: 8202264 [No Abstract] [Full Text] [Related]
32. The epidemiology of drug abuse: current issues. Interpretations and policy implications. Nowlis H. NIDA Res Monogr; 1977 Mar 25; (10):244-7. PubMed ID: 405606 [No Abstract] [Full Text] [Related]
34. Opposition to new marijuana research rules. Cimons M. Nat Med; 2000 Jan 25; 6(1):10. PubMed ID: 10613805 [No Abstract] [Full Text] [Related]
35. NIH panel identifies 11 principles for HIV therapy. Morey SS. Am Fam Physician; 1998 Sep 01; 58(3):783-6. PubMed ID: 9750543 [No Abstract] [Full Text] [Related]
36. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues. Celentano DD, Lucas G. Clin Infect Dis; 2007 Dec 15; 45 Suppl 4():S318-23. PubMed ID: 18190306 [Abstract] [Full Text] [Related]
37. Cholinesterase research at the National Institutes of Health, USA. Jett DA. Chem Biol Interact; 2008 Sep 25; 175(1-3):22-5. PubMed ID: 18550039 [Abstract] [Full Text] [Related]
38. Triple diagnosis: dual diagnosis and HIV disease, Part 1. Douaihy AB, Jou RJ, Gorske T, Salloum IM. AIDS Read; 2003 Jul 25; 13(7):331-2, 339-41. PubMed ID: 12889451 [Abstract] [Full Text] [Related]
39. Connecting the dots: integrating HIV and substance abuse. Domb M. Focus; 2003 Jul 25; 18(7):1-4. PubMed ID: 14672053 [No Abstract] [Full Text] [Related]
40. Reducing impediments to technology transfer in drug abuse programming. Brown BS. NIDA Res Monogr; 1995 Jul 25; 155():169-85. PubMed ID: 8594455 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]